Replimune
Price & Volume
Stats
See more52W Range | $1.50-$14.11 |
Market Cap | $1.1B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.83 |
News
See moreYahoo Finance • 2 days ago
This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 36% on Good News.
Yahoo Finance • 5 days ago
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (REPL)
Yahoo Finance • 5 days ago
REPL INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Replimune Group Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Yahoo Finance • 5 days ago
Replimune gains accelerated approval of Tudriqev for cutaneous melanoma
About
CEO | Dr. Sushil Patel Ph.D. |
Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 465 |